The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
SYNTHETIC LETHALITY AND SEMI-LETHALITY AMONG FUNCTIONALLY RELATED MUTANTS OF DROSOPHILA MELANOGASTER
Open accessAbstract
sex-linked mutant deep orange (dor) of Drosophila melanogaster is Tzonsible for a peculiar type of female sterility: mutant females produce no progeny when crossed to mutant males but yield some offspring (heterozygous daughters) when mated to wild-type males (MERRELL 1947). The effects of this mutant on embryonic development have been extensively studied by COUNCE (1956a) and more recently by HILDRETH and LUCCHESI (1967). In addition to the sterility phene, dor alters the pigmentation of the eyes (which are orange in color) and confers an abnormal spectrum of relative pteridine concentrations. An unusual characteristic of dor is that isoxanthopterin appears to be accumulated by mutant females (COUNCE 1957). During the course of preliminary investigations into the biochemical basis of dor female-sterility, art attempt was made to prevent the accumulation of isoxanthopterin in mutant females by genetic means. This resulted in the discovery of a highly specific synthetic lethal system involving dor and a non-allelic third chromosome mutant, rosy (ry) . The dor-ry system is similar to three other synthetic lethal systems, previously described in D. melanogaster: purpleoid (pd) and Purpleoider (Pdr) (BRIDGES 1922; as cited in BRIDGES and BREHME 1944) ; prune (pn) and Prune-killer (K-pn) ( STURTEVANT 1956) ; and Henna-recessiue-3 (Hnr3) and rosy (ry6) (TAIRA 1960; GOLDBERG, SCHALET and CHOVNICK 1962). A search was undertaken for the purpose of uncovering additional interactions among some of the mutants mentioned above. Since six of the latter affect eye color and/or pteridine levels, a number of other eye color mutants were tested. In addition, the female sterile mutant fused (fu) , similar in many respects to dor (although allowing lethal embryos to develop further than dor embryos (COUNCE 195613) ). was used in <some crosses. The results of these investigations are presented in this paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synthetic genetic interaction screens in yeast123,124 have demonstrated that thousands of combinations of individually viable mutations can jointly be lethal, and similar examples have been documented in Drosophila melanogaster and Caenorhabditis elegans125,126.”
From Rare and common variants: twenty arguments (2012) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
Woolf, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,724
The mutants of drosophila melanogaster
Bridges, C. B., & Brehme, K. S. (1944) · Carnegie Institution of Washington eBooks · Cited by 321
Studies on female-sterility genes inDrosophila melanogaster
Counce, S. J. (1956) · Molecular Genetics and Genomics · doi:10.1007/bf00737163 · Cited by 72
BIOCHEMICAL DIFFERENCES BETWEEN THE MUTANTS ROSY-2 AND MAROON-LIKE OF DROSOPHILA MELANOGASTER
FORREST, H. S., Hanly, E. W., & Lagowski, J. M. (1961) · Genetics · doi:10.1093/genetics/46.11.1455 · Cited by 41
Chovnick, A., Schalet, A., Kernaghan, R. P., & Talsma, J. (1962) · The American Naturalist · doi:10.1086/282236 · Cited by 22
Flagged first, then by citations
Research works printed but not linked: 1
- HapoRN, E., 1955 Letalfactoren in ihrer Bedeutung für Erbpathologie und Genphysiologie der Entwicklung. English translation, 1961, Wiley, N.Y.
Cited by
Sorted by citations
Items 101–141 of 141
WRN as a Novel Target of Synthetic Lethality: Current Advances and Future Perspectives
Zhang, Y., Zhang, J., Tang, C., Zhao, G., Pan, H., Bing, T., Li, Z., Xu, X. J., & Bian, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01114 · Cited by 6
Synthetic Lethality‐Based Targets and Their Exploration in Tumour Combination Strategies
Wu, L., Deng, Y., Lei, Z., Wang, Y., & Huang, S. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70756 · Cited by 4
Synthetic lethality in personalized cancer therapy
Pang, Y. K., Cheng, M., Chen, M., Zhao, K., Yin, Y., Liu, M., Zhang, J., & Zhong, C. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00080-3 · Cited by 4
PARP Inhibition as a Prototype for Synthetic Lethal Screens
Liu, X. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-311-4_9 · Cited by 4
NetVA: an R package for network vulnerability and influence analysis
Kumar, S., Pauline, G., & Vindal, V. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2303607 · Cited by 4
Male gonadal dysgenesis in a female‐sterile mutant of Drosophila melanogaster
Lucchesi, J. C., Counce, S. J., & Hildreth, P. E. (1968) · Journal of Experimental Zoology · doi:10.1002/jez.1401680404 · Cited by 4
Self-citationSL-scan identifies synthetic lethal interactions in cancer using metabolic networks
Zangene, E., Marashi, S., & Montazeri, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-42992-4 · Cited by 5
Jeusset, L. M., & McManus, K. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1740-3_8 · Cited by 3
BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications
Valarmathi, M. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100842 · Cited by 2
A Screen for Mutants Requiring Activation of the Unfolded Protein Response for Viability
Thibault, G., & Ng, D. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385928-0.00012-2 · Cited by 3
Guo, L., Li, S., Qian, B., Wang, Y.-Q., Duan, R., Jiang, W., Kang, Y., Dou, Y., Yang, G., Shen, L., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.10.015 · Cited by 3
Ferroptosis synergistically sensitizes wee1 inhibitors: a bibliometric study.
Xu, R., Wu, X., Zhao, Q., & Yang, Q. (2022) · PubMed Central · Cited by 3
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Chang, L., Shaw, K. L., Vázquez, F., & Sellers, W. R. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00929-9 · Cited by 7
Personalized Epigenetic Therapy—Chemosensitivity Testing
Pera, B., & Cerchietti, L. C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00028-8 · Cited by 2
Employing Cross-Species Approaches to Construct Humanized Genetic Interaction Networks
Jeusset, L. M., & McManus, K. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1740-3_6 · Cited by 2
Construction and analysis of sample-specific driver modules for breast cancer
Chen, Y., Li, H., & Sun, X. S. (2022) · BMC Genomics · doi:10.1186/s12864-022-08928-4 · Cited by 2
Han, Y., Wei, Y., Xie, Y., & Zheng, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117888 · Cited by 1
Loss-of-function variants in MARK2 cause neurodevelopmental disorder
Yang, Y., Shim, Y.-K., Miyake, N., Takada, S., Silva, S., Peters-Foitzick, A., Gupta, A. R., Neuhaus, E., Bradley, C. C., Taylor, C. M., et al. (2026) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2026.100600 · Cited by 1
Improving platinum-based treatments for advanced non-small cell lung cancer
Leung, A. W. Y. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0308666 · Cited by 1
Jabbour-Leung, N. A. (2015) · Digital Commons-TMC (Texas Medical Center)
Synthetic Sickness with Molecularly Targeted Agents Against the EGFR Pathway
Stanley, J. A., & Yang, E. S.-H. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_16
DNA Damage Repair Pathways and Synthetic Lethality
Ward, S. E. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677252.ch08
Hitting cancer where it hurts most
Kuiken, H. J. (2012) · Utrecht University Repository (Utrecht University)
Roman policier contemporain (Identité de présomption faible, Fiction publique, Exprimé)
Bassiere, J. (1998) · La Licorne
Computational paradigms for analyzing genetic interaction networks
Pons, C., Costanzo, M., Boone, C. M., & Myers, C. L. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012751.002
Deciphering cancer biology using boolean methods
Sinha, S., & Dill, D. L. (2016) · Proceedings · doi:10.1109/hldvt.2016.7748269
Reytan, S. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0347987
Henderson, M. C. (2008) · UA Campus Repository (The University of Arizona)
Brainstorming (in book and audiocassette formats)
Clark, C. H. (1991) · Journal for Quality and Participation
Jurj, A. M., Pop, L., Zănoagă, O., Ráduly, L., & Berindan‐Neagoe, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_356-1
BRCA Gene Mutations and Prostate Cancer
Kharaishvili, G., Kacheishvili, M., & Akhvlediani, G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108792
Personalized epigenetic therapy—chemosensitivity testing
Cerchietti, L. C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91367-6.00006-4
Dean, D. M., Codd, L. E., Constanza, R., & Segel, X. M. (2025) · PubMed Central · doi:10.17912/micropub.biology.001563
Shen, Y., Fan, K., Gökbağ, B., Sun, N., Chen, Y., Cheng, L., & Li, L. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013547
Jurj, A. M., Pop, L., Zănoagă, O., Ráduly, L., & Berindan-Neagoe, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_356
Pham, T. N., Vu, D., Dang, T., Nguyen, B. T., & Tran, T.-A. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-09321-9_17
Additional file 1 of Construction and analysis of sample-specific driver modules for breast cancer
Chen, Y., Li, H., & Sun, X. (2022) · Figshare · doi:10.6084/m9.figshare.21376387
A highly selective 1,2-dihydroquinoxaline derivative as a potent PRMT5-MTA complex inhibitor
Liu, Y., Jiao, Z., Zhang, D., Xu, X., Jia, Y., Wang, H., & Zhao, G. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118758
Synthetic Lethality in Cancer Therapy
Nune, S. S., & Halder, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-24738-5.00107-5
BindingDB Entry 50045098: Development of synthetic lethality anticancer therapeutics.
BindingDB (2016) · UC San Diego · doi:10.7270/q2vd714c
Metadata
- Authors
- Lucchesi, J. C.
- Corresponding author
- Lucchesi, John C
- ORCID
- Lucchesi, John C
- Venue
- Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1968-05-01
- Volume
- 59
- Issue
- 1
- Pages
- 37-44
- ISSN
- 0016-6731 (ISSN-L)
- 1943-2631
- OpenAlex
- W2123596976
- Cited by
- 139
- References
- 5
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 7 · 2012: 4
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurobiology and Insect Physiology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- synthetic lethality, female sterility, isoxanthopterin, pteridines, eye color mutants, Drosophila melanogaster, third chromosome
- MeSH terms
- Crosses, Genetic, Drosophila, Female, Genes, Lethal, Infertility, Female, Male, Mutation, Pigmentation, Pteridines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
